GLP-1 medications should be used under the care of a licensed medical provider
Recalls & Warnings September 12, 2012 Distribution of Weight Loss Product Containing DMAA Should Be Stopped Immediately, Warns FDA On August 28, 2012, the FDA issued a warning letter to Regeneca stating that the company's RegeneSlim, which was promoted as a dietary supplement for weight loss, is adulterated with dimethylamylamine (DMAA) and that failure to immediately cease distribution of this product could result in FDA
West Peptides supplies high-purity GHK-Cu in lyophilized form designed for controlled laboratory investigation and analytical research applications
Ketamine is a dissociative drug
Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity
Unique architectural features of mammalian mitochondrial protein synthesis